# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Mizuho analyst Anthony Petrone maintains LivaNova (NASDAQ:LIVN) with a Buy and raises the price target from $75 to $80.
Baird analyst Mike Polark maintains LivaNova (NASDAQ:LIVN) with a Neutral and raises the price target from $58 to $66.
Needham analyst Mike Matson reiterates LivaNova (NASDAQ:LIVN) with a Buy and maintains $72 price target.
LivaNova now expects revenue for full-year 2024 to grow between 6 and 7 percent on a constant-currency basis. When excluding th...
LivaNova (NASDAQ:LIVN) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.49 by 48....
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced that its wholly-owned U.S. subsidiary,...
Mizuho analyst Anthony Petrone maintains LivaNova (NASDAQ:LIVN) with a Buy and maintains $75 price target.
Needham analyst Mike Matson reiterates LivaNova (NASDAQ:LIVN) with a Buy and maintains $72 price target.